Search

Prognostic Value of the Systemic Immune-Inflammation Index in EGFR Mutation-Positive Lung Adenocarcinoma Patients Treated with Tyrosine Kinase Inhibitors

DOI : 10.20473/jr.v8-I.3.2022.133-139

Marsheilla Riska ⁽¹⁾, Haryati Haryati ⁽²⁾, Eko Suhartono ⁽³⁾, Tenri Ashari Wanahari ⁽⁴⁾

(1) Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Lambung Mangkurat University/Ulin General Hospital, Banjarmasin, Indonesia., Indonesia,

(2) Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Lambung Mangkurat University/Ulin General Hospital, Banjarmasin, Indonesia., Indonesia,

(3) Department of Biochemistry and Biomolecular, Faculty of Medicine, Lambung Mangkurat University, Banjarmasin, Indonesia., Indonesia,

(4) International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan., Taiwan, Province of China

133-139

Abstract : 1268

PDF : 538

DOI : 10.20473/jr.v8-I.3.2022.133-139

Prognosis of Tyrosine Kinase Inhibitor Therapy for Non-Small Cell Lung Cancer

DOI : 10.20473/jr.v11-I.2.2025.140-146

Agus Andreas Santoso ⁽¹⁾, Suryanti Dwi Pratiwi ⁽²⁾, Yani Jane Sugiri ⁽³⁾, Harun Al Rasyid ⁽⁴⁾, Aditya Sri Listyoko ⁽⁵⁾

(1) Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia., Indonesia,

(2) Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia., Indonesia,

(3) Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia., Indonesia,

(4) Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia., Indonesia,

(5) Doctoral Student, Division of Respiratory Medicine and Rheumatology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Tottori, Japan., Japan

140-146

Abstract : 196

PDF : 126

DOI : 10.20473/jr.v11-I.2.2025.140-146

Survival Analysis of Lung Adenocarcinoma Patients with Exon 19 Del and 21 L858R Mutations Receiving EGFR-TKI Treatment

DOI : 10.20473/jr.v9-I.2.2023.101-107

Stephen Johan Prasetyo ⁽¹⁾, Noni Novisari Soeroso ⁽²⁾, Setia Putra Tarigan ⁽³⁾, Erna Mutiara ⁽⁴⁾, Novia Nurul Faizah ⁽⁵⁾

(1) Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Sumatera Utara/Universitas Sumatera Utara Hospital, Medan, Indonesia., Indonesia,

(2) Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Sumatera Utara/Universitas Sumatera Utara Hospital, Medan, Indonesia., Indonesia,

(3) Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Sumatera Utara/Universitas Sumatera Utara Hospital, Medan, Indonesia., Indonesia,

(4) Department of Community Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia., Indonesia,

(5) Department of Cardiovascular Medicine, Graduate School of Medicine, Kobe University, Japan., Japan

101-107

Abstract : 574

PDF : 543

DOI : 10.20473/jr.v9-I.2.2023.101-107